|
시장보고서
상품코드
2055344
남성 요실금 시장 : 요실금 유형별, 제품 유형별(흡수성 제품)Male Urinary Incontinence Market, By Type of Incontinence, By Product Type Absorbent Products |
||||||
남성 요실금 시장은 2026년 72억 4,000만 달러로 추정되며, 2033년까지 109억 5,000만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 6.1%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 72억 4,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 6.10% | 2033년 시장 규모 예측 : | 109억 5,000만 달러 |
세계 남성 요실금 시장은 광범위한 헬스케어 산업에서 중요한 분야로, 전 세계 수백만 명의 남성에게 영향을 미치고 있음에도 불구하고 보고가 미흡한 경우가 많은 흔한 질환을 다루고 있습니다. 의도치 않게 방광 조절 능력을 상실하는 것이 특징인 남성 요실금에는 복압성 요실금, 절박성 요실금, 과다배출성 요실금, 혼합성 요실금 등 다양한 유형이 있으며, 각각 고유한 임상적 과제와 치료 요건이 있습니다. 이 질환은 주로 고령의 남성에게 영향을 미치며, 유병률은 나이가 들수록 현저히 증가하지만, 전립선 수술, 신경 질환, 외상 등의 요인으로 인해 젊은 층에게도 영향을 미칠 수 있습니다.
이 시장에는 흡수성 제품, 외부 카테터, 이식형 기기, 약물 요법, 그리고 요실금의 근본 원인을 관리 및 치료하기 위해 고안된 외과적 시술 등의 종합적인 치료 솔루션이 포함되어 있습니다. 삶의 질, 사회적 기능, 심리적 행복에 중대한 영향을 미치고 있음에도 불구하고, 남성의 요실금은 여전히 사회적 편견의 대상이 되고 있으며, 그 결과 환자들 사이에서 진단 지연이나 치료 지연이 발생하고 있습니다. 이는 결국 지역별 시장 역학이나 성장 패턴에 영향을 미치고 있습니다.
시장 역학
세계 남성 요실금 시장은 주로 몇 가지 상호 연관된 요인들에 의해 주도되고 있으며, 이러한 요인들이 결합되어 이 치료 분야 시장 확대와 혁신을 촉진하고 있습니다. 세계적인 고령화는 가장 중요한 시장 성장 요인으로 작용하고 있습니다. 요실금의 유병률은 노화에 따라, 특히 65세 이상 남성에서 현저히 증가하기 때문에 관리 솔루션이 필요한 환자층이 확대되고 있기 때문입니다. 의료기관 및 지원 단체의 인식 제고 캠페인과 교육 활동이 활발해짐에 따라, 남성 요실금에 대한 사회적 편견은 점차 해소되고 있으며, 더 많은 남성이 전문적인 의료 지원과 적절한 치료법을 찾고 있습니다. 고도화된 인공 요도 괄약근, 남성용 슬링, 최소 침습 수술 기술의 개발을 포함한 의료기기의 기술적 진보는 치료의 가능성을 넓히고 환자의 예후를 개선하고 있습니다.
또한, 수술이 필요한 양성 전립선 비대증이나 전립선암을 포함한 전립선 관련 질환의 유병률 증가는 남성 요실금 발생률에 직접적인 영향을 미치고 있으며, 이에 따라 예방 및 치료 솔루션에 대한 수요를 견인하고 있습니다. 그러나 시장 성장에는 이 질환에 따른 뿌리 깊은 사회적 편견이나 수치심과 같은 중대한 제약이 존재하며, 이러한 요인들이 보고 부족이나 진단 지연을 초래하여 시장 침투를 제한하고 있습니다. 높은 치료비, 특히 고도의 외과 수술이나 이식형 의료기기의 비용은 의료 인프라와 보험 적용 범위가 제한적인 개발도상국에서 치료 접근성에 있어 큰 장벽이 되고 있습니다. 의료기기 승인 및 의약품 개입과 관련된 규제의 복잡성은 제품 출시를 지연시키고 제조업체의 개발 비용을 증가시킬 수 있습니다. 그럼에도 불구하고 신흥 시장에는 큰 기회가 존재합니다. 이 분야에서 의료 인프라의 개선과 의료비 증가는 시장 확대의 새로운 길을 열어줄 것이며, 한편으로는 재생의료 및 생명공학 기반의 솔루션을 포함한 새로운 치료 접근법에 대한 지속적인 연구가 치료 패러다임에 혁명을 일으키고 미개척 시장의 가능성을 열어줄 것으로 기대됩니다.
본 조사의 주요 특징
- 본 조사에서는 다양한 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 주요 항목(기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적, 전략)을 바탕으로 전 세계 남성 요실금 시장의 주요 기업 프로파일을 작성하였습니다.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 유형 업그레이드, 시장 확대 및 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 남성 요실금 시장을 분석하는 데 활용되는 다양한 전략 매트릭스를 통해 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 남성 요실금 시장 : 요실금 유형별, 2021년-2033년
제5장 세계의 남성 요실금 시장 : 제품 유형별, 2021년-2033년
제6장 세계의 남성 요실금 시장 : 연령층별, 2021년-2033년
제7장 세계의 남성 요실금 시장 : 사용 형태별, 2021년-2033년
제8장 세계의 남성 요실금 시장 : 최종사용자별, 2021년-2033년
제9장 세계의 남성 요실금 시장 : 유통 채널별, 2021년-2033년
제10장 세계의 남성 요실금 시장 : 지역별, 2021년-2033년
제11장 경쟁 구도
제12장 애널리스트의 제안
제13장 참고 문헌 및 조사 방법
LSH 26.06.23Male Urinary Incontinence Market is estimated to be valued at USD 7.24 Bn in 2026 and is expected to reach USD 10.95 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.1% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 7.24 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 6.10% | 2033 Value Projection: | USD 10.95 Bn |
The global male urinary incontinence market represents a critical segment within the broader healthcare industry, addressing a prevalent yet often underreported condition affecting millions of men worldwide. Male urinary incontinence, characterized by the involuntary loss of bladder control, encompasses various types including stress incontinence, urge incontinence, overflow incontinence, and mixed incontinence, each presenting unique clinical challenges and treatment requirements. This condition predominantly affects older men, with prevalence rates increasing significantly with age, though it can also impact younger individuals due to factors such as prostate surgery, neurological disorders, or traumatic injuries.
The market encompasses a comprehensive range of therapeutic solutions including absorbent products, external catheters, implantable devices, pharmaceutical interventions, and surgical procedures designed to manage or treat the underlying causes of incontinence. Despite the significant impact on quality of life, social functioning, and psychological well-being, male urinary incontinence remains stigmatized, leading to underdiagnosis and delayed treatment seeking behavior among affected individuals, which consequently influences market dynamics and growth patterns across different geographical regions.
Market Dynamics
The global male urinary incontinence market is primarily driven by several interconnected factors that collectively propel market expansion and innovation within this therapeutic area. The aging global population serves as the most significant market driver, as the prevalence of urinary incontinence increases substantially with age, particularly among men over 65 years, creating a growing patient pool requiring management solutions. Rising awareness campaigns and educational initiatives by healthcare organizations and advocacy groups are gradually reducing the stigma associated with male incontinence, encouraging more men to seek professional medical help and appropriate treatment options. Technological advancements in medical devices, including the development of sophisticated artificial urinary sphincters, male slings, and minimally invasive surgical techniques, are expanding treatment possibilities and improving patient outcomes.
Additionally, the increasing prevalence of prostate-related disorders, including benign prostatic hyperplasia and prostate cancer requiring surgical intervention, directly contributes to the incidence of male urinary incontinence, thereby driving demand for both preventive and therapeutic solutions. However, market growth faces significant restraints including persistent social stigma and embarrassment associated with the condition, leading to underreporting and delayed diagnosis, which limits market penetration. High treatment costs, particularly for advanced surgical procedures and implantable devices, pose substantial barriers to access, especially in developing regions with limited healthcare infrastructure and insurance coverage. Regulatory complexities surrounding medical device approvals and pharmaceutical interventions can delay product launches and increase development costs for manufacturers. Nevertheless, substantial opportunities exist within emerging markets where improving healthcare infrastructure and increasing healthcare expenditure create new avenues for market expansion, while ongoing research into novel therapeutic approaches, including regenerative medicine and bioengineered solutions, promises to revolutionize treatment paradigms and capture untapped market potential.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global male urinary incontinence market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Coloplast A/S, ConvaTec Group PLC, Hollister Incorporated, Kimberly-Clark Corporation, Medtronic PLC, Boston Scientific Corporation, B. Braun Melsungen AG, Teleflex Incorporated, Wellspect HealthCare, Procter and Gamble Co., AbbVie Inc., Pfizer Inc., Laboratoires URGO, Ontex Healthcare, and C. R. Bard (BD).
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global male urinary incontinence market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global male urinary incontinence market.
Market Segmentation
- Type of Incontinence Insights (Revenue, USD Bn, 2021 - 2033)
- Stress Urinary Incontinence
- Urge Urinary Incontinence
- Overflow Urinary Incontinence
- Functional Urinary Incontinence
- Mixed Incontinence (Stress + Urge)
- Product Type Insights (Revenue, USD Bn, 2021 - 2033)
- Absorbent Products
- Pads and Guards
- Adult Diapers
- Protective Underwear
- Bed Protectors and Mattress Covers
- External Catheters (Urinary Sheaths)
- Latex Sheaths
- Silicone Sheaths
- Hydrocolloid Sheaths
- Internal Catheters
- Indwelling (Foley) Catheters
- Intermittent Catheters
- Other Devices and Systems
- Male Slings
- Artificial Urinary Sphincters
- Electrical Stimulation Devices/Penile Clamps
- Age Group Insights (Revenue, USD Bn, 2021 - 2033)
- 18-39 Years
- 40-59 Year
- 60-74 Years
- 75 Years and Above
- Usage Type Insights (Revenue, USD Bn, 2021 - 2033)
- Reusable
- Disposable
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Urology Clinics
- Home Healthcare Settings
- Long-Term Care Centers / Nursing Homes
- Ambulatory Surgical Centers
- Others
- Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)
- Offline
- Online
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Coloplast A/S
- ConvaTec Group PLC
- Hollister Incorporated
- Kimberly-Clark Corporation
- Medtronic PLC
- Boston Scientific Corporation
- Braun Melsungen AG
- Teleflex Incorporated
- Wellspect HealthCare
- Procter and Gamble Co.
- AbbVie Inc.
- Pfizer Inc.
- Laboratoires URGO
- Ontex Healthcare
- R. Bard (BD)
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Male Urinary Incontinence Market, By Type of Incontinence
- Global Male Urinary Incontinence Market, By Product Type
- Global Male Urinary Incontinence Market, By Age Group
- Global Male Urinary Incontinence Market, By Usage Type
- Global Male Urinary Incontinence Market, By End User
- Global Male Urinary Incontinence Market, By Distribution Channel
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Male Urinary Incontinence Market, By Type of Incontinence, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Stress Urinary Incontinence
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Urge Urinary Incontinence
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Overflow Urinary Incontinence
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Functional Urinary Incontinence
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Mixed Incontinence (Stress + Urge)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Male Urinary Incontinence Market, By Product Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Absorbent Products
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Pads and Guards
- Adult Diapers
- Protective Underwear
- Bed Protectors and Mattress Covers
- Pads and Guards
- External Catheters (Urinary Sheaths)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Latex Sheaths
- Silicone Sheaths
- Hydrocolloid Sheaths
- Latex Sheaths
- Internal Catheters
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Indwelling (Foley) Catheters
- Intermittent Catheters
- Other Devices and Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Male Slings
- Artificial Urinary Sphincters
- Electrical Stimulation Devices/Penile Clamps
- Male Slings
6. Global Male Urinary Incontinence Market, By Age Group, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- 18-39 Years
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- 40-59 Year
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- 60-74 Years
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- 75 Years and Above
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Male Urinary Incontinence Market, By Usage Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Reusable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Disposable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Male Urinary Incontinence Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Urology Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Home Healthcare Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Long-Term Care Centers / Nursing Homes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
9. Global Male Urinary Incontinence Market, By Distribution Channel, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Offline
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Online
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
10. Global Male Urinary Incontinence Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Type of Incontinence, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Usage Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Type of Incontinence, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Usage Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Type of Incontinence, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Usage Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Type of Incontinence, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Usage Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Type of Incontinence, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Usage Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Type of Incontinence, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Usage Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Sub-region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
11. Competitive Landscape
- Coloplast A/S
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- ConvaTec Group PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hollister Incorporated
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Kimberly-Clark Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medtronic PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Boston Scientific Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Braun Melsungen AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Teleflex Incorporated
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Wellspect HealthCare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Procter and Gamble Co.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AbbVie Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Laboratoires URGO
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ontex Healthcare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- R. Bard (BD)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
12. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
13. References and Research Methodology
- References
- Research Methodology
- About us
